» Articles » PMID: 31119443

4-Phenylbutyric Acid Protects Against Vasculitic Peripheral Neuropathy Induced by Ischaemia-reperfusion Through Attenuating Endoplasmic Reticulum Stress

Overview
Specialty Pharmacology
Date 2019 May 24
PMID 31119443
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Vasculitic peripheral neuropathy (VPN) is characterized by acute-to-subacute onset of painful sensory and motor disturbances that result from inflammatory obliteration of nerve blood vessels and subsequent ischaemic injury. Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of various peripheral neuropathies, and 4-phenylbutyric acid (4-PBA) is a chemical chaperone that inhibits ER stress signaling. We investigated the effects of 4-PBA on neuropathic pain associated with VPN induced by ischaemia-reperfusion (IR) and its underlying mechanisms. Male Sprague-Dawley rats were allocated to one of the following groups: sham, sham + 4-PBA, IR, and IR + 4-PBA. IR was achieved by occluding the femoral artery for 4 h followed by reperfusion. The behavioral parameters were assessed, and the expression of ER stress markers and nuclear factor (NF)-κB in sciatic nerves was measured. The behavioral data confirmed that VPN induced by IR leads to hindpaw mechano-allodynia and heat hyperalgesia as well as impaired hindpaw grip strength, indicating the development of neuropathic pain and debilitating symptoms of VPN. The molecular data revealed that VPN induced by IR activated ER stress sensors and effector molecules as well as NF-κB in the sciatic nerves, indicating the involvement of ER stress and NF-κB-mediated neuroinflammation. Notably, 4-PBA significantly reduced the expression of all these markers and improved all behavioral changes induced by IR. This study demonstrated that ER stress and NF-κB-mediated neuroinflammation contribute to VPN induced by IR and that 4-PBA has protective potential against neuropathic pain associated with VPN.

Citing Articles

Endoplasmic reticular stress as an emerging therapeutic target for chronic pain: a narrative review.

Kim H, Lee D, Shen S Br J Anaesth. 2024; 132(4):707-724.

PMID: 38378384 PMC: 10925894. DOI: 10.1016/j.bja.2024.01.007.


Therapeutic potential of endoplasmic reticulum stress inhibitors in the treatment of diabetic peripheral neuropathy.

Patel S, Pangarkar A, Mahajan S, Majumdar A Metab Brain Dis. 2023; 38(6):1841-1856.

PMID: 37289403 DOI: 10.1007/s11011-023-01239-x.


Dexmedetomidine and Ketamine Attenuated Neuropathic Pain Related Behaviors STING Pathway to Induce ER-Phagy.

Liu Y, Kuai S, Ding M, Wang Z, Zhao L, Zhao P Front Synaptic Neurosci. 2022; 14:891803.

PMID: 35645765 PMC: 9136071. DOI: 10.3389/fnsyn.2022.891803.


Dexmedetomidine Alleviated Endoplasmic Reticulum Stress via Inducing ER-phagy in the Spinal Cord of Neuropathic Pain Model.

Liu Y, Wang S, Wang Z, Ding M, Li X, Guo J Front Neurosci. 2020; 14:90.

PMID: 32184704 PMC: 7058658. DOI: 10.3389/fnins.2020.00090.

References
1.
Iida H, Nagasaka T, Shindo K, Shiozawa Z . Effect of the free radical scavenger edaravone on peripheral nerve ischemia-reperfusion injury. Muscle Nerve. 2009; 40(4):582-8. DOI: 10.1002/mus.21388. View

2.
Hong Y, Guo W, Wang W, Zhao L, Xiang M, Mei F . 4-Phenylbutyric Acid Attenuates Pancreatic Beta-Cell Injury in Rats with Experimental Severe Acute Pancreatitis. Int J Endocrinol. 2016; 2016:4592346. PMC: 5021485. DOI: 10.1155/2016/4592346. View

3.
Kwak K, Han C, Lee S, Jeon Y, Park S, Kim S . Reactive oxygen species in rats with chronic post-ischemia pain. Acta Anaesthesiol Scand. 2009; 53(5):648-56. DOI: 10.1111/j.1399-6576.2009.01937.x. View

4.
Muthuraman A, Ramesh M, Sood S . Ameliorative potential of montelukast on ischemia-reperfusion injury induced vasculitic neuropathic pain in rat. Life Sci. 2012; 90(19-20):755-62. DOI: 10.1016/j.lfs.2012.03.010. View

5.
de Almeida S, Picarote G, Fleming J, Carmo-Fonseca M, Azevedo J, de Sousa M . Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation. J Biol Chem. 2007; 282(38):27905-12. DOI: 10.1074/jbc.M702672200. View